Unicycive Therapeutics, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock (Details)

Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Mar. 13, 2024	Dec. 31, 2025	Dec. 31, 2024	Aug. 26, 2025	Jun. 11, 2025	Feb. 18, 2025	Dec. 19, 2024	Dec. 18, 2024	Oct. 31, 2024	Oct. 09, 2024	Aug. 14, 2024	Jul. 29, 2024	Jul. 25, 2024	Jul. 23, 2024	Jul. 05, 2024	Jun. 25, 2024	Jul. 31, 2021
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Gross proceed			$ (3,813)
Share issued price per share		$ 1,000															$ 50
Designated shares		10,000,000	10,000,000
Common stock shares issued		22,114,245	11,384,236
Preferred stock shares issued		0	0
Voting share of common stock		one
Divided shares		1,000
Series B-1 Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Proceed amount	$ 50,000
Purchase price	$ 1,000
Conversion price	$ 1
Series B-1 Preferred Stock [Member] \| Securities Purchase Agreement [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Share issued	50,000
Series B-1 Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Designated shares		50,000
Annual rate		8.00%
Annual dividend rate		14.00%
Outstanding common stock percentage		9.99%
Series B-2 Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Conversion price		$ 10
Designated shares		50,000	50,000
Common stock shares issued					300,000		300,300	144,100	43,800
Preferred stock shares issued		0	3,000												7,882
Outstanding common stock percentage		9.99%
Voting rights of preferred stock		one
Series B Convertible Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Common stock shares issued															4,211,800
Series B Preferred Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Outstanding common stock percentage		19.90%
Series B Certificate of Designation [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Conversion price		$ 1,000
Private Placement [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Gross proceed	$ 50,000
Common Stock [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Share issued		9,310,618	97,740
Share issued price per share	$ 1,000																$ 49.9
Common stock shares issued				652,900		140,000				550,000	350,200	135,900	375,600	355,000		595,600
Common Stock [Member] \| Series B Certificate of Designation [Member]
Issuance of Series B-1 Preferred Stock and Series B-2 Preferred Stock [Line Items]
Voting share of common stock		one